
Helus Pharma CEO to Present at Prestigious H.C. Wainwright Conference, Highlighting Pipeline Progress
Helus Pharma's CEO participation in a major investment conference underscores the company's strategic focus on advancing its novel serotonergic agonists for mental health, signaling potential investor interest and industry recognition.
Read full story






















